Core Insights - Intuitive Surgical, Inc. (ISRG) has a market capitalization of $158.1 billion and specializes in robotic-assisted surgical systems, notably the da Vinci Surgical System and Ion endoluminal system [1] Financial Performance - The company is expected to announce its fiscal Q3 2025 results on October 16, with analysts predicting an EPS of $1.59, a 1.9% increase from $1.56 in the same quarter last year [2] - For fiscal 2025, analysts forecast an EPS of $6.54, slightly up from $6.48 in fiscal 2024, with a projected 13.8% year-over-year growth to $7.44 in fiscal 2026 [3] Stock Performance - Over the past 52 weeks, ISRG shares have decreased by 9.3%, underperforming the S&P 500 Index's 15.6% gain, but faring better than the Health Care Select Sector SPDR Fund's 11.5% decline [4] - Following the Q2 2025 results announcement on July 22, ISRG shares fell 1.8% despite beating expectations, primarily due to concerns over slowing international system placements, which dropped to 179 due to budgetary pressures in Japan, China, and Europe [5] Analyst Ratings - The consensus view on ISRG stock is cautiously optimistic, with a "Moderate Buy" rating from 29 analysts: 18 recommend a "Strong Buy," 2 a "Moderate Buy," 8 a "Hold," and 1 a "Strong Sell" [6] - The average analyst price target for Intuitive Surgical is $597.12, suggesting a potential upside of 35.4% from current levels [6]